Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate

Gene Expression Profiling in Autoimmune Noninfectious Uveitis Disease

(2014) Z. Li et al.   JOURNAL OF IMMUNOLOGY

Actinohivin: specific amino acid residues essential for anti-HIV activity

(2010) Atsushi Takahashi et al.   JOURNAL OF ANTIBIOTICS

Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization

(2010) Elena Matei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated fromMicrocystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile

(2010) Dana Huskens et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A New Strategy to Identify and Annotate Human RPE-Specific Gene Expression

(2010) Judith C. Booij et al.   PLoS One

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

(2010) K. J. Doores et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity

(2010) Tinoush Moulaei et al.   STRUCTURE

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin

(2010) Kabamba B. Alexandre et al.   VIROLOGY

Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin

(2009) Yinan Liu et al.   BIOPOLYMERS

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

(2009) B. R. O'Keefe et al.   JOURNAL OF VIROLOGY

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

(2009) I Ibanez de Caceres et al.   ONCOGENE

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

(2009) B. R. O'Keefe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry

(2009) Caroline S. Chu et al.   PROTEOMICS

Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N

(2008) D SMEE et al.   ANTIVIRAL RESEARCH

Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent

(2008) Dana Huskens et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models

(2008) V. Buffa et al.   JOURNAL OF GENERAL VIROLOGY

Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome

(2008) Ana Knežević et al.   JOURNAL OF PROTEOME RESEARCH